Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Retained Earnings (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Retained Earnings for 6 consecutive years, with -$249.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 31.06% year-over-year to -$249.0 million, compared with a TTM value of -$249.0 million through Dec 2025, down 31.06%, and an annual FY2025 reading of -$249.0 million, down 31.06% over the prior year.
  • Retained Earnings was -$249.0 million for Q4 2025 at Treace Medical Concepts, down from -$239.6 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $191000.0 in Q3 2024 and bottomed at -$249.0 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$88.3 million, with a median of -$59.6 million recorded in 2022.
  • The sharpest move saw Retained Earnings surged 703.7% in 2023, then tumbled 125543.98% in 2025.
  • Year by year, Retained Earnings stood at -$41.9 million in 2021, then skyrocketed by 99.94% to -$27000.0 in 2022, then skyrocketed by 703.7% to $163000.0 in 2023, then plummeted by 116658.28% to -$190.0 million in 2024, then plummeted by 31.06% to -$249.0 million in 2025.
  • Business Quant data shows Retained Earnings for TMCI at -$249.0 million in Q4 2025, -$239.6 million in Q3 2025, and -$223.3 million in Q2 2025.